Metronidazole-induced reversible encephalopathy in a patient with facioscapulohumeral muscular dystrophy.
Athanasios
A
Papathanasiou
Vasiliki
V
Zouvelou
Stavroula
S
Kyriazi
Michael
M
Rentzos
Ioannis
I
Evdokimidis
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D008795:Metronidazole